7-Eleven, Inc. Celebrates 30 Years of Operation Chill®
Signature program underscores company's commitment to fostering
stronger, safer communities
Fostering stronger, safer communities is a core tenet of 7-Eleven, Inc.'s philanthropic mission to build thriving communities. As the program builds on three successful decades, 7-Eleven, Inc. remains committed to being a catalyst for connection — one Slurpee drink at a time.
"Operation Chill is more than just a free Slurpee drink coupon – it reinforces the power of small gestures to build big relationships," said
Today, the Operation Chill program has grown to include more than 1,300 law enforcement agencies across the
"Connecting with the community — especially our youth — is at the heart of what we do. A free Slurpee drink coupon may seem small, but it opens the door to meaningful conversations and trust-building moments between officers and kids," said Detective
Law enforcement agencies wishing to participate in the Operation Chill program can visit www.7-ElevenOperationChill.com to register, request Slurpee drink coupons, and access best practices, tools, and tips to help make Operation Chill a success in their local communities.
For a full list of law enforcement agencies participating in the Operation Chill outreach program, visit https://corp.7-eleven.com/corp/operation-chill. To learn more about 7-Eleven, Inc.'s philanthropic strategy, visit https://corp.7-eleven.com/corp/see-us-in-action.
About 7-Eleven, Inc.
7-Eleven, Inc. is the premier name in the
CONTACT: 7-Eleven, Inc.
Corporate Communications
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/7-eleven-inc-celebrates-30-years-of-operation-chill-302458133.html
SOURCE 7-Eleven, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VAPORESSO Marks 11th Anniversary, Advancing Tech Innovation and Strengthening Global Connections
- Fast-Track Vietnam Expands Airport and Urgent eVisa Support for International Travellers
- Akiram Therapeutics and ITM Sign Lutetium-177 Supply Agreement to Support Development of AKIR001 for the Treatment of Solid Tumors
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share